Understand the story, not the spin.
Recent Verilumia coverage about Bristol-Myers Squibb Company (BMY), including reporting-tone insights and market listing information.
Novartis shares surged on Tuesday after the Swiss pharmaceutical company announced positive results from two late-stage clinical trials of its oral multiple sclerosis drug, remibrutinib, showing it outperformed a riva...
Novartis has paused eight clinical trials of an experimental cell therapy for autoimmune and neurological diseases after three patients died from a severe immune reaction, a setback for a promising approach to treatin...
Verilumia 
